For every human disease, there are perhaps multiple pharmacological targets explored in drug development. Furthermore, there are many approaches to drug screening and validation that involve human cell culture and animal models. Human iPSC-derived disease models, 3D tissue models and classical pharmacological testing are all capabilities (services or tools) offered by REPROCELL. The disease focus category pages on the REPROCELL website are an attempt to summarize the key products or services related to these specific diseases. They are areas in which REPROCELL has knowledge and experience through contract research projects or product development.
REPROCELL’s Predictive Drug Discovery Services therapeutic areas include:
Predictive Drug Discovery Assay Services
Online Resources
Discover how testing your inflammatory skin compounds in fresh diseased tissue from human patients can help avoid clinical failure.
REPROCELL
Products
Services
© 2021 REPROCELL Inc. All rights reserved.
REPROCELL Inc. 日本語 MetLife Shin-yokohama 381, Bldg. 9F, 3-8-11 Shin-yokohama, Kohoku-ku, Yokohama, Kanagawa 222-0033, Japan
REPROCELL USA Inc. 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA
REPROCELL Europe Ltd. Thomson Pavilion, Todd Campus, West of Scotland Science Park, Acre Road, Glasgow, G20 0XA, United Kingdom
Bioserve Biotechnologies (India) PVT Ltd. Unit: D4-D7, 1st Floor, Industrial Estate, Moula Ali, Medchal-Malkajgiri Dist., Hyderabad-500040, Telangana, India